L1210 cells cultivated under the selection pressure of doxorubicin or vincristine express common mechanisms of multidrug resistance based on the overexpression of P-glycoprotein

Toxicology in Vitro

Volumn 20, Issue 8, 2006, Pages 1560-1568

  Boháčová, Viera ^a   Sulová, Zdena ^a   Dovinová, Ima ^b   Poláková, Eva ^a   Barančík, Miroslav ^c   Uhrík, Branislav ^a   Orlický, Jozef ^a   Breier, Albert ^a  

^a INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

^b INSTITUTE OF VIROLOGY   (Slovakia)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

ABC transporters; Doxorubicin; Multidrug resistance; P glycoprotein; Vincristine

Indexed keywords

CALCEIN; DOXORUBICIN; DYE; FLUO 3; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; VINCRISTINE;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CELL CULTURE; CELL LINE; CELL MEMBRANE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOSOL; DRUG SENSITIVITY; GENE OVEREXPRESSION; MOLECULAR DYNAMICS; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRESSURE; PROTEIN ANALYSIS; ULTRASTRUCTURE; WESTERN BLOTTING;

ANILINE COMPOUNDS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLUORESCEINS; FLUORESCENT DYES; GLUTATHIONE TRANSFERASE; LEUKEMIA L1210; MICE; MICROSCOPY, ELECTRON; P-GLYCOPROTEIN; VINCRISTINE; XANTHENES;

EID: 33749540488     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2006.07.011     Document Type: Article

References (54)

1. Abbott B.L. ABCG2 (BCRP) expression in normal and malignant hematopoietic cells. Hematol. Oncol. 21 3 (2003) 115-130
2. Abrahamse S.L., and Rechkemmer G. Identification of an organic anion transport system in the human colon carcinoma cell line HT29 clone 19A. Pflugers Arch. 441 4 (2001) 529-537
3. 2+-entry blockers, neuroleptics and local anaesthetics on P-glycoprotein-mediated vincristine resistance of L1210/VCR mouse leukaemic cell line. Drugs Exp. Clin. Res. 20 1 (1994) 13-18
4. Boháčová V., Kvačkajová J., Barančík M., Drobná Z., and Breier A. Glutathione S-transferase does not play a role in multidrug resistance of L1210/VCR cell line. Physiol. Res. 49 4 (2000) 447-453
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
6. Breier A., Barančík M., Sulová Z., and Uhrík B. P-glycoprotein - implication of metabolism of neoplastic cells and cancer therapy. Curr. Cancer Drug Targets 5 6 (2005) 457-468
7. Breier A., Drobná Z., and Barančík M. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells. Neoplasma 45 4 (1998) 248-253
8. Cantz T., Nies A.T., Brom M., Hofmann A.F., and Keppler D. MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of Hep G2 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 278 4 (2000) G522-G531
9. Cole S.P., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M., and Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258 5088 (1992) 1650-1654
10. Coley H.M., Workman P., and Twentyman P.R. Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression. Br. J. Cancer. 633 3 (1991) 351-357
11. Cui Y., Konig J., and Keppler D. Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol. Pharmacol. 60 5 (2001) 934-943
12. Doyle L.A., and Ross D.D. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene. 22 47 (2003) 7340-7358
13. Drummond I.A., Lee A.S., Resendez Jr. E., and Steinhardt R.A. Depletion of intracellular calcium stores by calcium ionophore A23187 induces the genes for glucose-regulated proteins in hamster fibroblasts. J. Biol. Chem. 262 26 (1987) 12801-12805
14. Eneroth A., Astrom E., Hoogstraate J., Schrenk D., Conrad S., Kauffmann H.M., and Gjellan K. Evaluation of a vincristine resistant Caco-2 cell line for use in a Calcein/AM extrusion screening assay for P-glycoprotein interaction. Eur. J. Pharm. Sci. 12 3 (2001) 205-214
15. Fiala R., Sulová Z., El-Saggan A.H., Uhrík B., Liptaj T., Dovinová I., Hanušovská E., Drobná Z., Barančík M., and Breier A. P-glycoprotein-mediated multidrug resistance phenotype of L1210/VCR cells is associated with decreases of oligo- and/or polysaccharide contents. Biochim. Biophys. Acta 1639 3 (2003) 213-224
16. Fu L.W., Pan Q.C., and Lin G.Y. Compared study on Fura-2/AM assay and MTT assay for screening multidrug resistant modulators. Yao Xue Xue Bao 32 6 (1997) 401-405 (in Chinese)
17. Fu L.W., Zhang Y.M., Liang Y.J., Yang X.P., and Pan Q.C. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Eur. J. Cancer 38 3 (2002) 418-426
18. Gollapudi S., Kim Ch.H., Tran B.-N., Sangha S., and Gupta S. Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells. Cancer Chemother. Pharmacol. 40 2 (1997) 150-158
19. Gottesman M.M., and Pastan I. Biochemistry of multidrug-resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62 (1993) 385-427
20. Hamada H., and Tsuruo T. Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance. 170- to 180-kilodalton membrane glycoprotein is an ATPase. J. Biol. Chem. 263 3 (1988) 1454-1458
21. Homolya L., Hollo Z., Germann U.A., Pastan I., Gottesman M.M., and Sarkadi B. Fluorescent cellular indicators are extruded by the multidrug resistance protein. J. Biol. Chem. 268 29 (1993) 21493-21496
22. Jedlitschky G., Leier I., Buchholz U., Barnouin K., Kurz G., and Keppler D. Transport of glutathione, glucuronate, and sulfate conjugatesn by the MRP gene-encoded conjugate export pump. Cancer Res. 56 5 (1996) 988-994
23. Ji B.-S., He L., and Liu G.-O. Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Life Sci. 77 18 (2005) 2221-2232
24. Karaszi E., Jakab K., Homolya L., Szakacs G., Hollo Z., Telek B., Kiss A., Rejto L., Nahajevszky S., Sarkadi B., and Kappelmayer J. Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia. Br. J. Haematol. 112 2 (2001) 308-314
25. Kupsáková I., Rybár A., Dočolomanský P., Drobná Z., Stein U., Walther W., Barančík M., and Breier A. Reversal of P-glycoprotein mediated vincristine resistance of L1210/VCR cells by analogues of pentoxifylline. A QSAR Study. Eur. J. Pharm. Sci. 21 2-3 (2004) 283-293
26. Laupeze B., Amiot L., Payen L., Drenou B., Grosset J.M., Lehne G., Fauchet R., and Fardel O. Multidrug resistance protein (MRP) activity in normal mature leukocytes and CD34-positive hematopoietic cells from peripheral blood. Life Sci. 68 11 (2001) 1323-1331
27. Litman T., Brangi M., Hudson E., Fetsch P., Abati A., Ross D.D., Miyake K., Resau J.H., and Bates S.E. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J. Cell. Sci. 113 Pt 11 (2000) 2011-2021
28. Loe D.W., Deeley R.G., and Cole S.P. Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. Cancer Res. 58 22 (1998) 5130-5136
29. Manocha S., Matrai Z., Osthoff M., Carter A., and Pettitt A.R. Correlation between cell size and CD38 expression in chronic lymphocytic leukaemia. Leuk. Lymphoma. 44 5 (2003) 797-800
30. Marbeuf-Gueye C., Broxterman H.J., Dubru F., Priebe W., and Garnier-Suillerot A. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells. Mol. Pharmacol. 53 1 (1998) 141-147
31. Masereeuw R., Notenboom S., Smeets P.H., Wouterse A.C., and Russel F.G. Impaired renal secretion of substrates for the multidrug resistance protein 2 in mutant transport-deficient (TR-) rats. J. Am. Soc. Nephrol. 14 11 (2003) 2741-2749
32. McGrath T., and Center M.S. Adriamycin resistance in HL60 cells in the absence of detectable P-glycoprotein. Biochem. Biophys. Res. Commun. 145 3 (1987) 1171-1176
33. Mealey K.L., Barhoumi R., Rogers K., and Kochevar D.T. Doxorubicin induced expression of P-glycoprotein in a canine osteosarcoma cell line. Cancer Lett. 126 2 (1998) 187-192
34. Moscow J.A., and Dixon K.H. Glutathione-related enzymes, glutathione and multidrug resistance. Cytotechnology 12 1-3 (1993) 155-170
35. Muller M.R., Lennartz K., Boogen C., Nowrousian M.R., Rajewsky M.F., and Seeber S. Cytotoxicity of adriamycin, idarubicin, and vincristine in acute myeloid leukemia: chemosensitization by verapamil in relation to P-glycoprotein expression. Ann. Hematol. 65 5 (1992) 206-212
36. 2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression. Br. J. Cancer. 64 6 (1991) 1011-1018
37. Orlický J., Sulová Z., Dovinová I., Fiala R., Zahradníková Jr. A., and Breier A. Functional fluo-3/AM Assay on P-Glycoprotein transport activity in L1210/VCR Cells by confocal microscopy. Gen. Physiol. Biophys. 23 3 (2004) 357-366
38. Poleková L., Barančík M., Mrázová T., Pirker R., Wallner J., Sulová Z., and Breier A. Adaptation of mouse leukemia-cells L1210 to vincristine - evidence for expression of p-glycoprotein. Neoplasma 39 2 (1992) 73-77
39. Prechtl S., Roellinghoff M., Scheper R., Cole S.P., Deeley R.G., and Lohoff M. The multidrug resistance protein 1: a functionally important activation marker for murine Th1 cells. J. Immunol. 164 2 (2000) 754-761
40. Renes J., de Vries E.G., Nienhuis E.F., Jansen P.L., and Muller M. ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1. Br. J. Pharmacol. 126 3 (1999) 681-688
41. Saitoh H., Arashiki Y., Oka A., Oda M., Hatakeyama Y., Kobayashi M., and Hosoi K. Arbekacin is actively secreted in the rat intestine via a different efflux system from P-glycoprotein. Eur. J. Pharm. Sci. 19 2-3 (2003) 133-140
42. Scheffer G.L., Kool M., Heijn M., de Haas M., Pijnenborg A.C., Wijnholds J., van Helvoort A., de Jong M.C., Hooijberg J.H., Mol C.A., Van der Linden M., de Vree J.M., van der Valk P., Elferink R.P., Borst P., and Scheper R.J. Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies. Cancer Res. 60 18 (2000) 5269-5277
43. Shen H., Kauvar L., and Tew K.D. Importance of glutathione and associated enzymes in drug response. Oncol. Res. 9 6-7 (1997) 295-302
44. Simon S.M., and Schindler M. Cell Biological Mechanisms of Multidrug Resistance in Tumors. Proc. Natl. Acad. Sci. USA 91 9 (1994) 3497-3504
45. Smitherman P.K., Townsend A.J., Kute T.E., and Morrow C.S. Role of multidrug resistance protein 2 (MRP2, ABCC2) in alkylating agent detoxification: MRP2 potentiates glutathione S-transferase A1-1-mediated resistance to chlorambucil cytotoxicity. J. Pharmacol. Exp. Ther. 308 1 (2004) 260-267
46. 2+. Biochem. Biophys. Res. Commun. 335 3 (2005) 777-784
47. Uhrík B., Tribulová N., Klobušická M., Barančík M., and Breier A. Characterization of morphological and histochemical changes induced by overexpression of P-glycoprotein in mouse leukemic cell line L1210. Neoplasma 41 2 (1994) 83-88
48. Uhrík, B., Sulová, Z., Barančík, M., Breier, A., 2005. Ultrastructural differences between sensitive and multidrug-resistant L1210 murine leukaemic cell lines. Proceedings of the 4th International Research Conference BioMedical Transporters 2005, August 14-18, St. Gallen, Switzerland, Abstract PX19, p. 67.
49. van der Pol M.A., Broxterman H.J., Pater J.M., Feller N., van der Maas M., Weijers G.W., Scheffer G.L., Allen J.D., Scheper R.J., van Loevezijn A., Ossenkoppele G.J., and Schuurhuis G.J. Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia. Haematologica 88 9 (2003) 134-147
50. Versantvoort C.H., Bagrij T., Wright K.A., and Twentyman P.R. On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP). Int. J. Cancer. 63 6 (1995) 855-862
51. Wang N., Tang Z.M., Zhang Y.P., and Ding Q.M. Doxorubicin cellular pharmacokinetics plays no role in chemosensitizing effect of verapamil on Swiss-3T3 cells. Zhongguo Yao Li Xue Bao 17 5 (1996) 402-406
52. Whelan R.D., Hosking L.K., and Hill B.T. A lack of adriamycin (ADR) resistance in Chinese hamster ovary (CHO) cells overexpressing P-glycoprotein (Pgp) following in vitro exposure to fractionated X-irradiation. Biochem. Soc. Trans. 19 2 (1991) 125S
53. Young L.C., Campling B.G., Cole S.P., Deeley R.G., and Gerlach J.H. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels. Clin. Cancer Res. 7 6 (2001) 1798-1804
54. Zaman G.J., Flens M.J., van Leusden M.R., de Haas M., Mulder H.S., Lankelma J., Pinedo H.M., Scheper R.J., Baas F., Broxterman H.J., and Borst P. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. USA 91 19 (1994) 8822-8826